Shimadzu's new preparative chromatography systems promises high-performance purification
The Nexera Prep HPLC series and Nexera UC Prep are designed to address the challenges of pharmaceutical industries
The Nexera Prep HPLC series and Nexera UC Prep are designed to address the challenges of pharmaceutical industries
Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer
An optimized, automated workflow enables continued growth of the clinical mass spectrometry service at this leading London Trust
Ribbon Bio Co-founder, Wladimir Labeikovsky, provides unique perspectives on synthetic DNA and discusses the company’s commitment to producing pure and accurate synthetic DNA molecules
Fapon’s new Shine i8000/9000 CLIA analyzer caters to high-volume clinical testing needs, while the company is also scaling up efforts to bring advanced cancer therapies to market
The AC Extraction Plate revolutionizes LC-MS sample preparation workflows for apolar small molecules. It uses a simple ‘pipette and shake protocol’ that eliminates filtration, centrifugation and solvent evaporation – ideal for automation.
The Frida Reader add-on module for the Fluent® Automation Workstation offers UV-based concentration and purity measurements of nucleic acids in a hanging drop.
Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of neurodegenerative disease associated peptides
New E. coli-based Cell-Free Expression System will accelerate synthetic biology research and protein discovery through expression from PCR products and gene fragments
Advanced ICP-MS technology provides new levels of ultralow detection and simplicity in a single high-performance solution
LabVantage LIMS 8.7 Portal provides external customer self-service access to LIMS while maintaining the laboratory’s data security
The National Center for Tumor Diseases and Protagen AG collaborate to improve information integration
New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer